Gaps in MASLD/MASH Education: A Quantitative and Qualitative Survey with Leaders of US Graduate Medical Education Programs
Alina M Allen,1 Anthony R Hoovler,2 Amy Articolo,3 Travis Fisher,4 Mazen Noureddin,5 Douglas Dieterich6 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; 2Liver Health, Novo Nordisk Inc., Plainsboro, NJ, USA; 3Global Medical Affairs, Novo Nordisk Inc., Plainsboro, NJ, US...
Saved in:
| Main Authors: | Allen AM, Hoovler AR, Articolo A, Fisher T, Noureddin M, Dieterich D |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-05-01
|
| Series: | Advances in Medical Education and Practice |
| Subjects: | |
| Online Access: | https://www.dovepress.com/gaps-in-masldmash-education-a-quantitative-and-qualitative-survey-with-peer-reviewed-fulltext-article-AMEP |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Naringenin attenuates early hepatocarcinogenesis induced by a MASH model
by: Linda Vanessa Márquez-Quiroga, et al.
Published: (2025-07-01) -
Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01) -
Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01) -
Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01) -
The effectiveness of the integrated use of gepadif, ezetrol and fosinopril in the nonalcoholic steatohepatitis in patients with hypertension stage II
by: O. S. Khukhlina, et al.
Published: (2017-03-01)